Institutional shares held 71.7 Million
400 calls
0 puts
Total value of holdings $444M
$2K calls
$0 puts
Market Cap $851M
134,627,008 Shares Out.
Institutional ownership 53.23%
# of Institutions 134


Latest Institutional Activity in CTKB

Top Purchases

Q3 2024
Citadel Advisors LLC Shares Held: 271K ($1.71M)
Q3 2024
State Street Corp Shares Held: 4.17M ($26.3M)
Q3 2024
Jacobs Levy Equity Management, Inc Shares Held: 183K ($1.15M)
Q3 2024
Morgan Stanley Shares Held: 1.07M ($6.74M)
Q3 2024
Barclays PLC Shares Held: 201K ($1.27M)

Top Sells

Q3 2024
Brown Capital Management LLC Shares Held: 9.49M ($60M)
Q3 2024
New York State Common Retirement Fund Shares Held: 2.09M ($13.2M)
Q3 2024
Millennium Management LLC Shares Held: 191K ($1.2M)
Q3 2024
Goldman Sachs Group Inc Shares Held: 1.02M ($6.46M)
Q3 2024
Deerfield Management Company, L.P. (Series C) Shares Held: 17.6K ($111K)

About CTKB

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.


Insider Transactions at CTKB

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
299K Shares
From 8 Insiders
Exercise of conversion of derivative security 299K shares
Sell / Disposition
354K Shares
From 10 Insiders
Payment of exercise price or tax liability 89.4K shares
Bona fide gift 200K shares
Open market or private sale 64.9K shares

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB